NeuroPace (NPCE) Stock Forecast & Price Target $8.95 -0.03 (-0.33%) (As of 11/18/2024 ET) Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NeuroPace - Analysts' Recommendations and Stock Price Forecast (2024) How MarketBeat Calculates Price Target and Consensus Rating MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Consensus Rating Moderate BuyBased on 6 Analyst RatingsSell0Hold1Buy5 Based on 6 Wall Street analysts who have issued ratings for NeuroPace in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 6 analysts, 1 has given a hold rating, and 5 have given a buy rating for NPCE. Consensus Price Target $14.6063.13% Upside According to the 6 analysts' twelve-month price targets for NeuroPace, the average price target is $14.60. The highest price target for NPCE is $22.00, while the lowest price target for NPCE is $8.00. The average price target represents a forecasted upside of 63.13% from the current price of $8.95. Get the Latest News and Ratings for NPCE and Related Stocks Enter your email address to receive the latest news and analysts' ratings for NeuroPace and its competitors. Enter your email to sign up for newsletter Sign Up NPCE Analyst Ratings Over TimeTypeCurrent Forecast11/19/23 to 11/18/241 Month Ago10/20/23 to 10/19/243 Months Ago8/21/23 to 8/20/241 Year Ago11/19/22 to 11/19/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy5 Buy rating(s)6 Buy rating(s)6 Buy rating(s)3 Buy rating(s)Hold1 Hold rating(s)1 Hold rating(s)1 Hold rating(s)2 Hold rating(s)Sell0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)0 Sell rating(s)Consensus Price Target$14.60$14.00$14.00$9.40Forecasted Upside63.13% Upside116.38% Upside93.37% Upside8.67% UpsideConsensus RatingModerate BuyModerate BuyModerate BuyModerate Buy Donald Trump can’t save you from this crisis (Ad)Elon Musk: “This Is The Most Destructive Force In History” Elon Musk claims a terrifying new economic force will put millions of Americans out of work. The ripple effects could nudge the US economy into a catastrophic tailspin. If this happens, you need to be prepared. That’s why a former Trump advisor is sharing his contingency plan with the public. What is Musk talking about?Get the full details now. NPCE Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History NPCE Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table NeuroPace Stock vs. The CompetitionTypeNeuroPaceMedical CompaniesS&P 500Consensus Rating Score 2.83 2.80 2.50Consensus RatingModerate BuyModerate BuyModerate BuyPredicted Upside62.58% Upside28,619.81% Upside9.78% UpsideNews Sentiment RatingPositive NewsSee Recent NPCE NewsPositive NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails11/13/2024Wells Fargo & Company3 of 5 stars Lower TargetOverweight ➝ Overweight$15.00 ➝ $13.00+58.73%8/14/2024Cantor Fitzgerald3 of 5 stars Reiterated RatingOverweight ➝ Overweight$18.00 ➝ $18.00+137.78%7/15/2024Morgan Stanley3 of 5 stars Lower TargetEqual Weight ➝ Equal Weight$9.50 ➝ $8.00+1.14%1/30/2024Leerink PartnrsSubscribe to MarketBeat All Access for the recommendation accuracy ratingM. KratkySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform1/30/2024Leerink PartnersSubscribe to MarketBeat All Access for the recommendation accuracy rating Initiated CoverageOutperform$22.00+49.15%12/27/2023Lake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy rating Reiterated RatingBuy ➝ Buy$12.00+21.95%11/7/2023JPMorgan Chase & Co.Subscribe to MarketBeat All Access for the recommendation accuracy rating Boost TargetOverweight ➝ Overweight$6.00 ➝ $9.00+24.65%Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 07:22 PM ET. NPCE Forecast - Frequently Asked Questions What is NeuroPace's forecast for 2025? According to the research reports of 6 Wall Street equities research analysts, the average twelve-month stock price forecast for NeuroPace is $14.60, with a high forecast of $22.00 and a low forecast of $8.00. Should I buy or sell NeuroPace stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NeuroPace in the last twelve months. There is currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" NPCE shares. Does NeuroPace's stock price have much upside? According to analysts, NeuroPace's stock has a predicted upside of 63.13% based on their 12-month stock forecasts. What analysts cover NeuroPace? NeuroPace has been rated by research analysts at Wells Fargo & Company in the past 90 days. Do Wall Street analysts like NeuroPace more than its competitors? Analysts like NeuroPace more than other "medical" companies. The consensus rating score for NeuroPace is 2.83 while the average consensus rating score for "medical" companies is 2.80. Learn more on how NPCE compares to other companies. Stock Forecasts and Research Tools Related Companies TELA Stock Forecast XAIR Stock Forecast PAVM Stock Forecast LQDA Stock Forecast IRMD Stock Forecast CATX Stock Forecast SIBN Stock Forecast FNA Stock Forecast KIDS Stock Forecast AXGN Stock Forecast Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Trump’s EPIC Stock Market Rally (Ad)Putting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to Jim, getting in now could turn $10,000 into as much as $265,000 by Inauguration Day.Play this epic Trump rally for every dollar of profit possible. This page (NASDAQ:NPCE) was last updated on 11/18/2024 by MarketBeat.com Staff From Our PartnersTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...Crypto 101 Media | SponsoredWhy Buffett, Bezos & Congress Are Rushing Into This SectorWhy are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredTech funds are hemorrhaging cash: Sell this stock nowSomething very strange is happening to U.S. stocks following President Trump's victory... And this could s...Chaikin Analytics | SponsoredBuffett’s Selling Out: Is Your 401(k) About to Get Wiped Out?Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of...Golden Crest | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump’s EPIC Stock Market RallyPutting HUGE gain chances in the hands of hardworking, patriotic Americans like YOU. In fact, according to ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NeuroPace, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NeuroPace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NPCE Stock Alerts